Table 1.
Patient demographic characteristics
| Characteristic | 0.1% Tβ4 (n=36) | Placebo (n=36) | Total ITT, safety population (n=72) |
|---|---|---|---|
| Mean age, years (SD) | 57.1 (12.07) | 55.3 (12.76) | 56.2 (12.37) |
| Female, na (%) | 29 (80.6%) | 25 (69.4%) | 54 (75.0%) |
| Male, na (%) | 7 (19.4%) | 11 (30.6%) | 18 (25.0%) |
| White, na (%) | 33 (91.7%) | 34 (94.4%) | 67 (93.1%) |
| Asian, na (%) | 2 (5.6%) | 1 (2.8%) | 3 (4.2%) |
| Black or African American, na (%) | 0 (0.0%) | 1 (2.8%) | 1 (1.4%) |
| Other, na (%) | 1 (2.8%) | 0 (0.0%) | 1 (1.4%) |
| Non-Hispanic, na (%) | 34 (94.4%) | 36 (100.0%) | 70 (97.2%) |
| Iris color, nb (%) | |||
| Black | 4 (5.6%) | 0 (0.0%) | 4 (2.8%) |
| Blue | 28 (38.9%) | 30 (41.7%) | 58 (40.3%) |
| Brown | 28 (38.9%) | 26 (36.1%) | 54 (37.5%) |
| Hazel | 6 (8.3%) | 8 (11.1%) | 14 (9.7%) |
| Green | 6 (8.3%) | 8 (11.1%) | 14 (9.7%) |
| Other | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Notes: na, number of subjects; nb, number of eyes.
Abbreviation: ITT, intention to treat.